This does not rule out a role for the ErbB2-IRS cooperation in antiestrogen resistance, but suggests that ErbB2 amplified human breast cancers may have sufficient ErbB2-induced regulation and signaling. This evidence concerns the gene ERBB2 and breast carcinoma.